Compare Cassava Sciences Inc (FLNA) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Vanguard Short Term Corporate Bond ETF — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Vanguard Short Term Corporate Bond ETF trades at $78.52. Which is the better fit depends on your goals.
| FLNA | VCSH | |
|---|---|---|
Market Cap | $47.75M | — |
Sector | Health | Fixed Income |
52-Week High | $4.64 | $80.20 |
52-Week Low | $0.87 | $78.41 |
Enterprise Value | -$34.93M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
